MEN
The Men's Magazine

The Times Real Estate

.
Men Magazine

.


UniSA researchers have identified three new biomarkers for prostate cancer to help identify and differentiate potentially aggressive cases of the disease which kills more than 300,000 men each year.An international team of scientists led by UniSA Professor of Molecular Medicine Doug Brooks has made the breakthrough, which assists pathologists when visualising prostate cancer in patient tissue samples.
 
The new biomarkers, when used together, will assist clinicians in determining which patients require immediate, radical treatment compared to those who need close monitoring. Oncology tests, through the examinations of genetic markers like the ones you can avail from easydna.com.au, can help identify an individual's risk levels.
 
With more than one million men diagnosed with prostate cancer worldwide each year, the research breakthrough is significant.
 
The UniSA-based team has collaborated with the Australian company Envision Sciences on the technology to improve patient management and treatment outcomes.

“It is anticipated this will lead to long-term improvements in the way prostate cancer is diagnosed and graded,” Prof Brooks says.
 
“The biomarkers are remarkably sensitive and specific in accurately visualising the progress of the cancer and confirming its grade. This discovery has led to the commercial development of a test designed to determine how advanced and aggressive the cancer is and whether immediate treatment is needed.”
 
Envision Sciences, which funded the development and translation of the technology at UniSA, has signed a commercialisation agreement with the largest tissue diagnostic pathology company in the US, Quest Diagnostics, to take the technology into clinical practice.
 
Pending a successful outcome in the US, it is expected that clinical trials using the innovative technology will be undertaken in Australia.
 
Describing the breakthrough as “life saving,” UniSA Deputy Vice Chancellor Research and Enterprise Professor Marnie Hughes-Warrington AO says the partnership between UniSA and Envision Sciences is an exciting development in cancer research.
 
“This technology represents a shift in the way clinicians can grade and predict the aggressiveness of prostate cancer. We look forward to seeing the difference it makes in coming years.”

How to Boost Your Beard Growth With Vitamins?

Growing a thick and full beard is a goal for many men. While genetics play a significant role in determining the thickness and f...

TENA Men helps prostate cancer survivors Wear it with Confidence

An estimated 1 in 4 Australian men have visited the doctor about incontinence*, but this taboo health  issue is rarely openly ...

Is Laser Tattoo Removal a Safe Procedure?

Laser tattoo removal has become the go-to method for those seeking to erase unwanted ink. However, with any medical procedure, c...

How AI-Powered Landing Pages Shorten the Customer Journey

Gone are the days of a linear digital customer journey for consumers. Instead, with multiple channels and touchpoints, it becomes increasingly complicated. Where they might have arrived on a landing...

How Email Marketers Can Use A/B Testing Beyond Subject Lines

A/B testing, also known as split testing, is a vital tool in every email marketer’s toolkit. It helps remove the guesswork from campaign creation by allowing marketers to experiment with different e...